Health Trials

Registry Platform Gastric/Esophageal Cancer (SAPHIR)

ConditionsEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsoriOMEDICO AG

About this trial

The registry aims to collect and analyse information on the antineoplastic treatment of patients with metastatic esophageal, gastric or gastroesophageal junction cancer, treated in palliative intention in daily routine practice in Germany.

Eligibility criteria

Qualifiers

Histologically proven stage IV (metastatic) ESCC, EAC, GAC or GEJAC

Planned palliative systemic first-line therapy

Age >= 18 years

Signed informed consent (IC)

Disqualifiers

No systemic therapy for ESCC, EAC, GAC or GEJAC

Trial design

Treatments tested in this trial

  • Routine care as per site standard

Treatment groups

1,900 Participants
are divided into 4 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Multiple sites, GemanyRecruiting Multiple LocationsGermanyGermany

Sponsors and collaborators

iOMEDICO AG

Lead sponsor

Source ClinicalTrials.gov